ghk cu peptide topical serum Copper Face – Radiant, Anti-Aging Skincare backed firming serum built around GHK Shop GHK-Cu Peptides | Copper

The Good Face Project

Vanhee C, et al

Key findings include: GLP3 monotherapy achieved 22.8-24.2% mean weight reduction at 48 weeks in phase 2 obesity trials (8-12 mg doses) Cagrilintide monotherapy produced 10.8% weight loss over 26 weeks in phase 2 studies (2.4 mg dose) CagriSema combination (cagrilintide + semaglutide) achieved 20.4% weight loss at 68 weeks in phase 3 REDEFINE trials Combination approaches consistently outperformed single-agent therapies across multiple dose ranges Studies demonstrated that 100% of participants receiving GLP3 8 mg or higher achieved at least 5% weight loss, with 75-83% achieving 15% or greater weight reduction[9]

Each section includes specific numbers for different goals, whether you are targeting skin rejuvenation , hair restoration , wound healing , or general anti-aging benefits